Turkey vs. Zolgensma: the battle over the world's most expensive drug
Turkey and Novartis are in a stand-off over approval of Zolgensma - a $2.1 million gene therapy.
Source: swissinfo.ch
Mine Sanem News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Mine Sanem. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Mine Sanem Today - Breaking & Trending Today